Event Details

Spark Therapeutics, Inc. at European Association for Haemophilia and Allied Disorders (EAHAD)

Wednesday, February 1, 2017 2:00 p.m. CT  
Title
Spark Therapeutics, Inc. at European Association for Haemophilia and Allied Disorders (EAHAD)
Date / Time
02/01/17 2:00 p.m. CT
Location
Marriott Rive Gauche Hotel & Conference Centre
Paris  FR
Description
  • Katherine A. High, M.D., president and chief scientific officer, will participate in the Pfizer Corporate Symposium on Wednesday, Feb. 1, at 2 p.m. CET
  • Marcus Carr, M.D., head of clinical development, will present previously disclosed data during a presentation on “Preliminary Interim Data from Phase 1/2 Trial: SPK-9001 Adeno-associated Virus Mediated Gene Transfer for Haemophilia B Achieves Sustained Therapeutic Factor IX Activity Levels Without Repetitive Infusions” at the Hot Topics session on Friday, Feb. 3, at 12:30 p.m. CET